BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · Real-Time Price · USD
7.66
-0.85 (-9.99%)
At close: Jun 27, 2025, 4:00 PM
7.76
+0.10 (1.25%)
After-hours: Jun 27, 2025, 7:56 PM EDT
BioSig Technologies Revenue
BioSig Technologies had revenue of $26.00K in the twelve months ending March 31, 2025, down -3.70% year-over-year. In the year 2024, BioSig Technologies had annual revenue of $40.00K with 122.22% growth.
Revenue (ttm)
$26.00K
Revenue Growth
-3.70%
P/S Ratio
7,146.38
Revenue / Employee
$5,200
Employees
5
Market Cap
185.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.00K | 22.00K | 122.22% |
| Dec 31, 2023 | 18.00K | -268.00K | -93.71% |
| Dec 31, 2022 | 286.00K | -155.00K | -35.15% |
| Dec 31, 2021 | 441.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
BSGM News
- 19 days ago - BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors - GlobeNewsWire
- 24 days ago - BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor - GlobeNewsWire
- 4 weeks ago - BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM - Business Wire
- 4 weeks ago - CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) - GlobeNewsWire
- 4 weeks ago - BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer - GlobeNewsWire
- 7 weeks ago - BioSig Enters into an LOI to Merge with Streamex Exchange Corp. - GlobeNewsWire
- 3 months ago - BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market - GlobeNewsWire
- 8 months ago - BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement - GlobeNewsWire